Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses

Anglesio, 2013, Type-specific cell line models for type-specific ovarian cancer research, PLoS ONE, 8, e72162, 10.1371/journal.pone.0072162

Bannert, 2004, Retroelements and the human genome: new perspectives on an old relation, Proc. Natl. Acad. Sci. USA, 101, 14572, 10.1073/pnas.0404838101

Baylin, 2011, A decade of exploring the cancer epigenome - biological and translational implications, Nat. Rev. Cancer, 11, 726, 10.1038/nrc3130

Bénit, 2003, Characterization of the low-copy HERV-Fc family: evidence for recent integrations in primates of elements with coding envelope genes, Virology, 312, 159, 10.1016/S0042-6822(03)00163-6

Berger, 2008, Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies, Clin. Cancer Res., 14, 3044, 10.1158/1078-0432.CCR-07-4079

Bernard, 2012, Ultraviolet radiation damages self noncoding RNA and is detected by TLR3, Nat. Med., 18, 1286, 10.1038/nm.2861

Bestor, 1996, Creation of genomic methylation patterns, Nat. Genet., 12, 363, 10.1038/ng0496-363

Blaise, 2005, Functional characterization of two newly identified Human Endogenous Retrovirus coding envelope genes, Retrovirology, 2, 19, 10.1186/1742-4690-2-19

Blond, 1999, Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family, J. Virol., 73, 1175, 10.1128/JVI.73.2.1175-1185.1999

Brahmer, J. (2015). Phase II Anti-PD1 Epigenetic Priming Study in NSCLC (NA_00084192). https://clinicaltrials.gov/ct2/show/NCT01928576.

Brahmer, 2010, Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates, J. Clin. Oncol., 28, 3167, 10.1200/JCO.2009.26.7609

Brahmer, 2012, Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, N. Engl. J. Med., 366, 2455, 10.1056/NEJMoa1200694

Chen, 2004, Over 20% of human transcripts might form sense-antisense pairs, Nucleic Acids Res., 32, 4812, 10.1093/nar/gkh818

Chiappinelli, 2012, Reduced DICER1 elicits an interferon response in endometrial cancer cells, Mol. Cancer Res., 10, 316, 10.1158/1541-7786.MCR-11-0520

Cooper, 2015, Genetic engineering of T cells to target HERV-K, an ancient retrovirus on melanoma, Clin. Cancer Res., 21, 3241, 10.1158/1078-0432.CCR-14-3197

de Parseval, 2003, Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins, J. Virol., 77, 10414, 10.1128/JVI.77.19.10414-10422.2003

Ding, 2014, Peroxisomal MAVS activates IRF1-mediated IFN-λ production, Nat. Immunol., 15, 700, 10.1038/ni.2924

Ding, 2014, Epigenetic reprogramming of the type III interferon response potentiates antiviral activity and suppresses tumor growth, PLoS Biol., 12, e1001758, 10.1371/journal.pbio.1001758

Domcke, 2013, Evaluating cell lines as tumour models by comparison of genomic profiles, Nat. Commun., 4, 2126, 10.1038/ncomms3126

Drake, 2006, Mechanisms of immune evasion by tumors, Adv. Immunol., 90, 51, 10.1016/S0065-2776(06)90002-9

Egan, 2004, Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia, Proc. Natl. Acad. Sci. USA, 101, 12604, 10.1073/pnas.0405077101

Faghihi, 2008, Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase, Nat. Med., 14, 723, 10.1038/nm1784

Gimenez, 2010, Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control, Nucleic Acids Res., 38, 2229, 10.1093/nar/gkp1214

Grow, 2015, Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells, Nature, 522, 221, 10.1038/nature14308

Guan, 2015, Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma, Sci. Rep., 5, 7857, 10.1038/srep07857

Henke, 2015, Selective expression of sense and antisense transcripts of the sushi-ichi-related retrotransposon--derived family during mouse placentogenesis, Retrovirology, 12, 9, 10.1186/s12977-015-0138-8

Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc. Natl. Acad. Sci. USA, 93, 9821, 10.1073/pnas.93.18.9821

Hodi, 2010, Improved survival with ipilimumab in patients with metastatic melanoma, N. Engl. J. Med., 363, 711, 10.1056/NEJMoa1003466

Hurst, 2014, Activation of the innate immune response by endogenous retroviruses, J. Gen. Virol., 96, 1207, 10.1099/vir.0.000017

Ivashkiv, 2014, Regulation of type I interferon responses, Nat. Rev. Immunol., 14, 36, 10.1038/nri3581

Issa, 2005, Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection, Nat. Clin. Pract. Oncol., 2, S24, 10.1038/ncponc0355

James, 2013, DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11, Epigenetics, 8, 849, 10.4161/epi.25500

Juergens, 2011, Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer, Cancer Discov., 1, 598, 10.1158/2159-8290.CD-11-0214

Kaminskas, 2005, Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes, Clin. Cancer Res., 11, 3604, 10.1158/1078-0432.CCR-04-2135

Karikó, 2005, Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA, Immunity, 23, 165, 10.1016/j.immuni.2005.06.008

Karpf, 1999, Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells, Proc. Natl. Acad. Sci. USA, 96, 14007, 10.1073/pnas.96.24.14007

Karpf, 2004, Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine, Mol. Pharmacol., 65, 18, 10.1124/mol.65.1.18

Karpf, 2009, Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP, Mol. Cancer Res., 7, 523, 10.1158/1541-7786.MCR-08-0400

Kulaeva, 2003, Epigenetic silencing of multiple interferon pathway genes after cellular immortalization, Oncogene, 22, 4118, 10.1038/sj.onc.1206594

Larsen, 2009, Syncytin immunoreactivity in colorectal cancer: potential prognostic impact, Cancer Lett., 280, 44, 10.1016/j.canlet.2009.02.008

Laska, 2013, (Some) cellular mechanisms influencing the transcription of human endogenous retrovirus, HERV-Fc1, PLoS ONE, 8, e53895, 10.1371/journal.pone.0053895

Le, 2015, PD-1 blockade in tumors with mismatch-repair deficiency, N. Engl. J. Med., 372, 2509, 10.1056/NEJMoa1500596

Leach, 1996, Enhancement of antitumor immunity by CTLA-4 blockade, Science, 271, 1734, 10.1126/science.271.5256.1734

Leonova, 2013, p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs, Proc. Natl. Acad. Sci. USA, 110, E89, 10.1073/pnas.1216922110

Li, 2014, Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers, Oncotarget, 5, 587, 10.18632/oncotarget.1782

Löwer, 1993, A general method for the identification of transcribed retrovirus sequences (R-U5 PCR) reveals the expression of the human endogenous retrovirus loci HERV-H and HERV-K in teratocarcinoma cells, Virology, 192, 501, 10.1006/viro.1993.1066

Maksakova, 2008, Keeping active endogenous retroviral-like elements in check: the epigenetic perspective, Cell. Mol. Life Sci., 65, 3329, 10.1007/s00018-008-8494-3

Mankan, 2014, Cytosolic RNA:DNA hybrids activate the cGAS-STING axis, EMBO J., 33, 2937, 10.15252/embj.201488726

Matei, 2012, Epigenetic resensitization to platinum in ovarian cancer, Cancer Res., 72, 2197, 10.1158/0008-5472.CAN-11-3909

Matousková, 2006, CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues, Exp. Cell Res., 312, 1011, 10.1016/j.yexcr.2005.12.010

Mi, 2000, Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis, Nature, 403, 785, 10.1038/35001608

O’Hagan, 2011, Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands, Cancer Cell, 20, 606, 10.1016/j.ccr.2011.09.012

Odunsi, 2014, Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer, Cancer Immunol. Res., 2, 37, 10.1158/2326-6066.CIR-13-0126

Pardoll, 2012, The blockade of immune checkpoints in cancer immunotherapy, Nat. Rev. Cancer, 12, 252, 10.1038/nrc3239

Platanias, 2005, Mechanisms of type-I- and type-II-interferon-mediated signalling, Nat. Rev. Immunol., 5, 375, 10.1038/nri1604

Rizvi, 2015, Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer, Science, 348, 124, 10.1126/science.aaa1348

Robek, 2005, Lambda interferon inhibits hepatitis B and C virus replication, J. Virol., 79, 3851, 10.1128/JVI.79.6.3851-3854.2005

Rote, 2004, The role of human endogenous retroviruses in trophoblast differentiation and placental development, Placenta, 25, 673, 10.1016/j.placenta.2004.02.008

Ruebner, 2013, Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region, PLoS ONE, 8, e56145, 10.1371/journal.pone.0056145

Rycaj, 2015, Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells, Clin. Cancer Res., 21, 471, 10.1158/1078-0432.CCR-14-0388

Santoni, 2012, HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency, Retrovirology, 9, 111, 10.1186/1742-4690-9-111

Schaefer, 2009, Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines, Cancer Res., 69, 8127, 10.1158/0008-5472.CAN-09-0458

Schreiber, 2011, Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion, Science, 331, 1565, 10.1126/science.1203486

Sistigu, 2014, Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy, Nat. Med., 20, 1301, 10.1038/nm.3708

Snyder, 2014, Genetic basis for clinical response to CTLA-4 blockade in melanoma, N. Engl. J. Med., 371, 2189, 10.1056/NEJMoa1406498

Stengel, 2010, Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation, Genes Chromosomes Cancer, 49, 401, 10.1002/gcc.20751

Stewart, 2003, Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, 9, 493, 10.1261/rna.2192803

Stresemann, 2006, Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines, Cancer Res., 66, 2794, 10.1158/0008-5472.CAN-05-2821

Strick, 2007, Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta, J. Mol. Med., 85, 23, 10.1007/s00109-006-0104-y

Strissel, 2012, Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: emergence of new molecular targets, Oncotarget, 3, 1204, 10.18632/oncotarget.679

Su, 2012, Bidirectional regulation between WDR83 and its natural antisense transcript DHPS in gastric cancer, Cell Res., 22, 1374, 10.1038/cr.2012.57

Sun, 2013, Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway, Science, 339, 786, 10.1126/science.1232458

Tarallo, 2012, DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88, Cell, 149, 847, 10.1016/j.cell.2012.03.036

Topalian, 2012, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer, N. Engl. J. Med., 366, 2443, 10.1056/NEJMoa1200690

Topalian, 2015, Immune checkpoint blockade: a common denominator approach to cancer therapy, Cancer Cell, 27, 450, 10.1016/j.ccell.2015.03.001

Tristem, 2000, Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database, J. Virol., 74, 3715, 10.1128/JVI.74.8.3715-3730.2000

Tsai, 2012, Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells, Cancer Cell, 21, 430, 10.1016/j.ccr.2011.12.029

Turner, 2001, Insertional polymorphisms of full-length endogenous retroviruses in humans, Curr. Biol., 11, 1531, 10.1016/S0960-9822(01)00455-9

Verhaak, 2013, Prognostically relevant gene signatures of high-grade serous ovarian carcinoma, J. Clin. Invest., 123, 517

Villesen, 2004, Identification of endogenous retroviral reading frames in the human genome, Retrovirology, 1, 32, 10.1186/1742-4690-1-32

Walsh, 1998, Transcription of IAP endogenous retroviruses is constrained by cytosine methylation, Nat. Genet., 20, 116, 10.1038/2413

Wang-Johanning, 2001, Expression of human endogenous retrovirus k envelope transcripts in human breast cancer, Clin. Cancer Res., 7, 1553

Wang-Johanning, 2003, Quantitation of HERV-K env gene expression and splicing in human breast cancer, Oncogene, 22, 1528, 10.1038/sj.onc.1206241

Wang-Johanning, 2007, Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer, Int. J. Cancer, 120, 81, 10.1002/ijc.22256

Wang-Johanning, 2012, Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors, J. Natl. Cancer Inst., 104, 189, 10.1093/jnci/djr540

Weber, 2015, Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial, Lancet Oncol., 16, 375, 10.1016/S1470-2045(15)70076-8

Wilkerson, 2010, ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking, Bioinformatics, 26, 1572, 10.1093/bioinformatics/btq170

Wrangle, 2013, Alterations of immune response of non-small cell lung cancer with azacytidine, Oncotarget, 4, 2067, 10.18632/oncotarget.1542

Xiong, 1997, COBRA: a sensitive and quantitative DNA methylation assay, Nucleic Acids Res., 25, 2532, 10.1093/nar/25.12.2532

Zamarin, 2014, Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy, Sci. Transl. Med., 6, 226ra32, 10.1126/scitranslmed.3008095